Samsung Bioepis teams up with Takeda to develop original biotech drugs

SEOUL (Reuters) - Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news